Return to Clinical Trials Search Results
GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)
Main Objective
The main objectives are:
To investigate the patient characteristics influencing the choice of antithrombotic
treatment for the prevention of stroke in non-valvular AF patients
To collect real world data on important outcome events of antithrombotic treatments for
the prevention of stroke.
Further Objective
The following further objectives are defined:
To explore subgroups with different risk profiles impacting safety and effectiveness of
dabigatran.
To investigate compliance and persistence of antithrombotic treatments for the prevention
of stroke.
To collect data on treatment strategies in patients with vascular and bleeding events.
To collect real-world data on potential side effects of antithrombotic treatments.
Main Objective
The main objectives are:
To investigate the patient characteristics influencing the choice of antithrombotic
treatment for the prevention of stroke in non-valvular AF patients
To collect real world data on important outcome events of antithrombotic treatments for
the prevention of stroke.
Further Objective
The following further objectives are defined:
To explore subgroups with different risk profiles impacting safety and effectiveness of
dabigatran.
To investigate compliance and persistence of antithrombotic treatments for the prevention
of stroke.
To collect data on treatment strategies in patients with vascular and bleeding events.
To collect real-world data on potential side effects of antithrombotic treatments.
Recruitment Status
Past Studies